Many internal projects have been sitting on the back burner for years, this tags delivery capability back behind competitors! The ephemeral Bionix has not given DXC an advantage? Why?
Final year figures are likely closer to $15b than $17b - is this wrong?
The revenue drop off would have been arrested if investment had been made 24 months ago (easy/cheap shot) why though is investment still not being made.. serious leadership question!
Bionix is just an agile delivery kit, all competitors engineering teams have the same - this is where execs are so out of touch :-) - it is really like electricity now, not a differentiator! committing to funding engineering is a differentiator! Resources to make Platform X real. PDXC was 3 years in PPTX...
Let's see if the corporate PR 'stazi' get this zapped? At wits end now, will continue till I get an interview with competitor.